Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations, conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade.

Technologies

Sign in to see how your skills match this stack
Sign In
Tech DNA
GCP
Security
CAPA
Other
GCP
Stack modernity Established
43/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
Industry adoption
GCP
13%
CAPA
3%
Share of companies in the same industry that use each technology.

Growth

Hiring Momentum
28/100
Slowing
Open positions
0
0 opened / 0 closed in 30 days
Hiring Dynamics 0%